324 related articles for article (PubMed ID: 31995565)
1. A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa.
Semakula JR; Mouton JP; Jorgensen A; Hutchinson C; Allie S; Semakula L; French N; Lamorde M; Toh CH; Blockman M; Sekaggya-Wiltshire C; Waitt C; Pirmohamed M; Cohen K
PLoS One; 2020; 15(1):e0227458. PubMed ID: 31995565
[TBL] [Abstract][Full Text] [Related]
2. A "Bundle of Care" to Improve Anticoagulation Control in Patients Receiving Warfarin in Uganda and South Africa: Protocol for an Implementation Study.
Jorgensen AL; Orrell C; Waitt C; Toh CH; Sekaggya-Wiltshire C; Hughes DA; Allen E; Okello E; Tatz G; Culeddu G; Asiimwe IG; Semakula JR; Mouton JP; Cohen K; Blockman M; Lamorde M; Pirmohamed M
JMIR Res Protoc; 2023 Jul; 12():e46710. PubMed ID: 37467034
[TBL] [Abstract][Full Text] [Related]
3. Poor anticoagulation control in patients taking warfarin at a tertiary and district-level prothrombin clinic in Cape Town, South Africa.
Ebrahim I; Bryer A; Cohen K; Mouton JP; Msemburi W; Blockman M
S Afr Med J; 2018 May; 108(6):490-494. PubMed ID: 30004329
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation control among patients on vitamin K antagonists in nine countries in Sub-Saharan Africa.
Mwita JC; Francis JM; Pillay C; Ogah OS; Goshu DY; Agyekum F; Musonda JM; James MC; Tefera E; Kabo T; Ditlhabolo KI; Ndlovu K; Ayodele AY; Mkomanga WP; Chillo P; Damasceno A; Folson AA; Oyekunle A; Tebuka E; Kalokola F; Forrest K; Dunn H; Karaye K; Jean-Pierre FL; Oljira CF; Tadesse TA; Taiwo TS; Nwafor CE; Omole O; Anakwue R; Cohen K
J Thromb Thrombolysis; 2024 Apr; 57(4):613-621. PubMed ID: 38478250
[TBL] [Abstract][Full Text] [Related]
5. INR goal attainment and oral anticoagulation knowledge of patients enrolled in an anticoagulation clinic in a Veterans Affairs medical center.
Baker JW; Pierce KL; Ryals CA
J Manag Care Pharm; 2011 Mar; 17(2):133-42. PubMed ID: 21348546
[TBL] [Abstract][Full Text] [Related]
6. The Quality of Anticoagulation Therapy among Warfarin-Treated Patients with Atrial Fibrillation in a Primary Health Care Setting.
Urbonas G; Valius L; Šakalytė G; Petniūnas K; Petniūnienė I
Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30650565
[No Abstract] [Full Text] [Related]
7. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
[TBL] [Abstract][Full Text] [Related]
8. Quality of warfarin management in primary care: Determining the stability of international normalized ratios using a nationally representative prospective cohort.
Liu S; Singer A; McAlister FA; Peeler W; Heran BS; Drummond N; Manca DP; Allan GM; Korownyk C; Kolber MR; Greiver M; Garrison SR
Can Fam Physician; 2019 Jun; 65(6):416-425. PubMed ID: 31189630
[TBL] [Abstract][Full Text] [Related]
9. Profile and anticoagulation outcomes of patients on warfarin therapy in an urban hospital in Cape Town, South Africa.
Sonuga BO; Hellenberg DA; Cupido CS; Jaeger C
Afr J Prim Health Care Fam Med; 2016 May; 8(1):e1-8. PubMed ID: 27247158
[TBL] [Abstract][Full Text] [Related]
10. Vitamin K-dependent anticoagulant use and level of anticoagulation control in sub-Saharan Africa: protocol for a retrospective cohort study.
Mwita JC; Damasceno A; Chillo P; Ogah OS; Cohen K; Oyekunle A; Tefera E; Francis JM;
BMJ Open; 2022 Feb; 12(2):e057166. PubMed ID: 35105600
[TBL] [Abstract][Full Text] [Related]
11. A simple method to identify patients on long-term warfarin who may derive the most benefit from new oral anticoagulants.
Carrier M; Kimpton M; Wells PS; Langlois N; Kherani S; Le Gal G
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):812-5. PubMed ID: 24914740
[TBL] [Abstract][Full Text] [Related]
12. Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study.
Menzin J; Boulanger L; Hauch O; Friedman M; Marple CB; Wygant G; Hurley JS; Pezzella S; Kaatz S
Ann Pharmacother; 2005 Mar; 39(3):446-51. PubMed ID: 15701783
[TBL] [Abstract][Full Text] [Related]
13. Quality of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation in the community setting.
Han SY; Palmeri ST; Broderick SH; Hasselblad V; Rendall D; Stevens S; Tenaglia A; Velazquez E; Whellan D; Wagner G; Heitner JF
J Electrocardiol; 2013; 46(1):45-50. PubMed ID: 23063241
[TBL] [Abstract][Full Text] [Related]
14. Defining time in therapeutic range for busy clinicians: frequency of dose changes is a good surrogate marker to identify patients with suboptimal anticoagulation with warfarin.
Vijenthira A; Le Gal G; Castellucci LA; Carrier M
Thromb Res; 2014 Sep; 134(3):584-6. PubMed ID: 25037497
[TBL] [Abstract][Full Text] [Related]
15. Attainment of Target in Therapeutic Range of International Normalized Ratio and Correlates Among Patients on Warfarin Therapy at Jimma Medical Center, Jimma, Ethiopia.
Jada AU; Disassa GM; Melesse BH; Abafogi MM; Abera EG; Jibicho KH; Tukeni KN
Clin Ther; 2024 Apr; 46(4):354-359. PubMed ID: 38429119
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of warfarin utilisation in two primary healthcare clinics in the Cape Town area.
Njovane XW; Fasinu PS; Rosenkranz B
Cardiovasc J Afr; 2013 Mar; 24(2):19-23. PubMed ID: 23750346
[TBL] [Abstract][Full Text] [Related]
17. [A Retrospective Evaluation of the Impact of Multi-disciplinary Approach for Improving the Quality of Anticoagulation Therapy in Ambulatory Patients with Non-valvular Atrial Fibrillation Receiving Warfarin].
Ohgushi A; Nakayama N; Namiki A; Nagashima A; Ogawa R; Akazawa M; Echizen H
Yakugaku Zasshi; 2019; 139(9):1177-1183. PubMed ID: 31474634
[TBL] [Abstract][Full Text] [Related]
18. Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial.
Singer DE; Hellkamp AS; Yuan Z; Lokhnygina Y; Patel MR; Piccini JP; Hankey GJ; Breithardt G; Halperin JL; Becker RC; Hacke W; Nessel CC; Mahaffey KW; Fox KA; Califf RM;
J Am Heart Assoc; 2015 Mar; 4(3):e001349. PubMed ID: 25736441
[TBL] [Abstract][Full Text] [Related]
19. Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial.
Van Spall HG; Wallentin L; Yusuf S; Eikelboom JW; Nieuwlaat R; Yang S; Kabali C; Reilly PA; Ezekowitz MD; Connolly SJ
Circulation; 2012 Nov; 126(19):2309-16. PubMed ID: 23027801
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
